InMed to Participate in Upcoming Investor Conferences in April and May 2022
Vancouver BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, announces that the Company’s executive team… Read More




